These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 656120)

  • 1. Deprenil: loss of selectivity for inhibition of B-type MAO after repeated treatment.
    Waldmeier PC; Felner AE
    Biochem Pharmacol; 1978 Mar; 27(5):801-2. PubMed ID: 656120
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced selectivity of pargyline as an inhibitor of type B monoamine oxidase in harmaline-treated rats.
    Fuller RW; Hemrick SK
    Life Sci; 1978 Mar; 22(12):1083-6. PubMed ID: 642716
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some cardiovascular effects of monoamine oxidase inhibitors in unanaesthetized rats.
    Marwood JF; Huston V; Wall KT
    Clin Exp Pharmacol Physiol; 1985; 12(2):161-8. PubMed ID: 3839173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontogeny of multiple forms of monoamine oxidase in mouse brain.
    Chordikian FJ; Tabakoff B; Alivisatos SG
    Brain Res; 1975 Aug; 93(2):301-8. PubMed ID: 809102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolism of indolealkylamines by type A and B monoamine oxidase of brain.
    Neff NH; Yang HY; Goridis C; Bialek D
    Adv Biochem Psychopharmacol; 1974; 11(0):51-8. PubMed ID: 4845688
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of monoamine oxidase by N-phenacyl-cyclopropylamine.
    Fuller RW; Hemrick SK; Mills J
    Biochem Pharmacol; 1978; 27(18):2255-61. PubMed ID: 728176
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative effects of irreversible MAO inhibitors in vivo.
    Felner AE; Waldmeier PC
    Biochem Pharmacol; 1979 Apr; 28(7):995-1002. PubMed ID: 444293
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism of phenylethylamine in rat isolated perfused lung: evidence for monoamine oxidase 'type B' in lung.
    Bakhle YS; Youdim MB
    Br J Pharmacol; 1976 Jan; 56(1):125-7. PubMed ID: 1252659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-[2-(o-iodophenoxy)ethyl]cyclopropylamine hydrochloride (LY121768), a potent and selective irreversible inhibitor of type A monoamine oxidase.
    Fuller RW; Hemrick-Luecke SK; Molloy BB
    Biochem Pharmacol; 1983 Apr; 32(7):1243-9. PubMed ID: 6847714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract]   [Full Text] [Related]  

  • 13. Steric influence on inhibition of monoamine oxidase forms by 2,3-dichloro-alpha-methylbenzylamine.
    Fuller RW; Hemrick SK
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):199-202. PubMed ID: 663404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of MAO inhibitors using postmortem human brain tissue: biochemical and therapeutic implications.
    Reynolds GP; Riederer P
    Mod Probl Pharmacopsychiatry; 1983; 19():255-9. PubMed ID: 6408410
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition patterns of monoamine oxidase in sub-fractions of rat brain mitochondria in presence of some selective inhibitors.
    Mitra C; Guha SR
    Biochem Pharmacol; 1979 Apr; 28(7):1135-7. PubMed ID: 444271
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of monoamine oxidase by clorgyline and deprenyl in circumventricular structures of rat brain.
    Kinemuchi H; Wakui Y; Arai Y; Kamijo K
    Biochem Pharmacol; 1980 Oct; 29(20):2871-4. PubMed ID: 6776962
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transformation of mitochondrial monoaminoxidases types A and B].
    Shatemirova KK; Vervkina IV; Gorkin VZ
    Biull Eksp Biol Med; 1977 Jun; 83(6):669-70. PubMed ID: 884293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac).
    Leonardi ET; Azmitia EC
    Neuropsychopharmacology; 1994 Jul; 10(4):231-8. PubMed ID: 7945733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute and repeated administration of amiflamine on monoamine oxidase inhibition in the rat.
    Ask AL; Fagervall I; Jonze M; Kelder D; Nygren R; Ross SB
    Biochem Pharmacol; 1984 Sep; 33(18):2839-47. PubMed ID: 6477643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.